Literature DB >> 15457399

[Virus etiology of inflammatory cardiomyopathy].

R Kandolf1.   

Abstract

Molecular biological methods such as in situ hybridization and the polymerase chain reaction (PCR) have confirmed the pathogenetic role of enteroviruses and primarily coxsackieviruses of group B (CVB) in the induction and maintenance of inflammatory cardiomyopathy. More recently, additional viruses such as adenoviruses (ADV), various herpes viruses and increasingly parvovirus B19 (PVB19) have been identified as potential cardiotropic agents in the human heart. The different cell tropism of cardiotropic viruses implicates distinct pathogenetic principles. Whereas cardiac myocytes are target cells for infection with enteroviruses and adenoviruses with consecutive virus-induced cytolysis, PVB19-associated inflammatory cardiomyopathy is characterized by infection of intracardiac endothelial cells of small arterioles and veins, which may be associated with endothelial dysfunction, impairment of myocardial microcirculation, penetration of inflammatory cells and secondary myocyte necrosis.

Entities:  

Mesh:

Year:  2004        PMID: 15457399     DOI: 10.1055/s-2004-831863

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  9 in total

1.  [Serious clinical course of myocarditis with "apical ballooning": first presentation of pathogenicity of HHV6 subtype A in myocarditis].

Authors:  B Bigalke; K Klingel; A E May; M Beyer; T Hövelborn; R Kandolf; M Gawaz
Journal:  Internist (Berl)       Date:  2005-11       Impact factor: 0.743

2.  [Lymphocytic myocarditis in a patient with metastatic clear cell renal cell carcinoma treated with Nivolumab].

Authors:  R Sauer; P Kiewe; M Desole; M Schuler; F Theissig; A Roth; T Mairinger
Journal:  Pathologe       Date:  2017-11       Impact factor: 1.011

3.  [102 patients with suspected myocarditis : Clinical presentation, diagnostics, therapy and prognosis].

Authors:  S Streuber; F Noack; D Stoevesandt; A Schlitt
Journal:  Herz       Date:  2017-01-18       Impact factor: 1.443

4.  Molecular phenotypes of human parvovirus B19 in patients with myocarditis.

Authors:  C-Thomas Bock; Anja Düchting; Friederike Utta; Eva Brunner; Bui Tien Sy; Karin Klingel; Florian Lang; Meinrad Gawaz; Stephan B Felix; Reinhard Kandolf
Journal:  World J Cardiol       Date:  2014-04-26

Review 5.  [Molecular mechanisms and consequences of cardiac viral infections].

Authors:  R Kandolf; B Bültmann; K Klingel; C-T Bock
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

Review 6.  Coronary microvascular dysfunction: an update.

Authors:  Filippo Crea; Paolo G Camici; Cathleen Noel Bairey Merz
Journal:  Eur Heart J       Date:  2013-12-23       Impact factor: 29.983

7.  [The heart in viral infections].

Authors:  S Pankuweit; B Maisch
Journal:  Internist (Berl)       Date:  2010-07       Impact factor: 0.743

8.  Coxsackievirus B3 and adenovirus infections of cardiac cells are efficiently inhibited by vector-mediated RNA interference targeting their common receptor.

Authors:  H Fechner; S Pinkert; X Wang; I Sipo; L Suckau; J Kurreck; A Dörner; K Sollerbrant; H Zeichhardt; H-P Grunert; R Vetter; H-P Schultheiss; W Poller
Journal:  Gene Ther       Date:  2007-03-22       Impact factor: 5.250

Review 9.  Non-invasive imaging in the diagnosis of acute viral myocarditis.

Authors:  Michael Jeserich; Stavros Konstantinides; Gabor Pavlik; Christoph Bode; Annette Geibel
Journal:  Clin Res Cardiol       Date:  2009-09-11       Impact factor: 5.460

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.